Advances and Prospects in the Control of Biofilm-Related Fungal Infections by Natural Products
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Plant-Derived Antibiotics".
Deadline for manuscript submissions: closed (15 February 2024) | Viewed by 1781
Special Issue Editor
Special Issue Information
Dear Colleagues,
Biofilm formation is an important virulence factor of fungi and contributes towards the resistance to host immune responses as well as to antifungal resistance and environmental stresses. Biofilm-related fungal infections are generally more severe than those caused by fungi alone, leading to increased antimicrobial resistance and prolonging the time required for host recovery. In addition, the available anti-biofilm therapeutic arsenal is limited, and the development of new drugs has been necessary. Therefore, the search for alternative drugs with low resistance rates and fewer side effects remains a major challenge. A considerable number of studies on medicinal plants and alternative compounds, such as secondary metabolites, bioactive, nanoparticle biosynthesis, phenolic compounds, essential oils, and extracts, have been performed, as well as studies related to the prevention or treatment of fungal infections by probiotic bacteria. However, further research on the effects and treatment on fungal biofilms is needed.
The main mission of this Special Issue will be to discover the advances and perspectives on the control and treatment of fungal biofilms by natural products. We believe that the contributions published in this issue will help us significantly expand our knowledge on alternative therapies to control fungal biofilms and will provide a high-quality source of information as well as inspiration for many experts in the field.
Prof. Dr. Melyssa Negri
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fungal biofilm
- natural compounds
- anti-biofilm molecules
- photodynamic inactivation
- treatment
- probiotic
- nanoparticles
- quorum-sensing inhibitors